Table: Torii Pharmaceutical - Q1 parent results

Torii Pharmaceutical Co

28/04/2023 07:00

Apr 28 (Reuters)- 
             Torii Pharmaceutical Co Ltd 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Mar 31, 2023        Mar 31, 2022     Dec 31, 2023 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             11.81               10.96            50.90    
                 (+7.8 pct)                           (+4.1 pct)  
  Operating     loss 437 mln             1.29             4.10    
                                     (+87.3 pct)      (-26.0 pct) 
  Recurring     loss 404 mln             1.25             4.40    
                                     (+91.6 pct)      (-20.5 pct) 
  Net           loss 288 mln           882 mln            3.10    
                                    (+102.3 pct)      (-21.4 pct) 
  EPS          loss 10.28 yen         31.40 yen       110.33 yen  
  Ann Div                            100.00 yen       100.00 yen  
  -Q2 div                             24.00 yen        50.00 yen  
  -Q4 div                             76.00 yen        50.00 yen  
  
  NOTE - Torii Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4551.T